| Name | Title | Contact Details |
|---|
Ergatta is changing the motivation that moves people. We are a team of bright, driven, and innovative thinkers on a mission to build a new consumer category: game-based home fitness.
Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.
CHAD Therapeutics, Inc. (CHAD) was established to develop, produce and market respiratory care devices designed to improve the efficiency of oxygen delivery systems for both home and hospital treatment of patients who require supplemental oxygen.
AdventHealth is a faith-based, non-profit health care system headquartered in Altamonte Springs, Florida, that operates facilities within nine states across the United States.
Centerstone is a not-for-profit health system providing mental health and substance use disorder treatments. Services are available nationally through the operation of outpatient clinics, residential programs, the use of telehealth and an inpatient hospital. Centerstone also features specialized programs for the military community, therapeutic foster care, children`s services and employee assistance programs. Centerstone`s Research Institute provides guidance through research and technology, leveraging the best practices for use in all our communities. Centerstone`s Foundation secures philanthropic resources to support the work and mission of delivering care that changes people`s lives.